Hepatitis, Alcoholic Clinical Trial
Official title:
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
To determine the efficacy and safety S-adenosyl-l-methionine in alcoholic hepatitis with cholestasis.
randomize first time for core treatment stage for 6 weeks, then randomized second time for extend treatment for 42 weeks. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00205049 -
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
|
Phase 1 | |
| Recruiting |
NCT04142723 -
Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).
|
||
| Completed |
NCT00913757 -
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
|
||
| Active, not recruiting |
NCT02404636 -
Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis
|
N/A | |
| Completed |
NCT01968382 -
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
|
Phase 2 | |
| Enrolling by invitation |
NCT04234139 -
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
|